PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	205-214	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	17-48	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	205-214	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	50-60	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	205-214	vascular endothelial growth factor A	Rattus norvegicus	66-100	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	205-214	vascular endothelial growth factor A	Rattus norvegicus	102-106	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	340-349	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	17-48	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	340-349	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	50-60	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	340-349	vascular endothelial growth factor A	Rattus norvegicus	66-100	
15289360-6	2004	Up-regulation of hypoxia inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) at both mRNA and protein levels were detected in the groups receiving ligation and ligation with cisplatin, whereas a decreased level of von Hippel-Lindau tumor suppressor protein was identified in the group receiving ligation with cisplatin.	Cisplatin	340-349	vascular endothelial growth factor A	Rattus norvegicus	102-106	
15289360-7	2004	Sodium salicylate enhanced expression of von Hippel-Lindau tumor suppressor protein but down-regulated HIF-1alpha and VEGF levels after ligation with or without cisplatin.	Sodium Salicylate	0-17	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	103-113	
15289360-7	2004	Sodium salicylate enhanced expression of von Hippel-Lindau tumor suppressor protein but down-regulated HIF-1alpha and VEGF levels after ligation with or without cisplatin.	Sodium Salicylate	0-17	vascular endothelial growth factor A	Rattus norvegicus	118-122	
15289360-9	2004	In vitro study revealed that under hypoxic condition, both cisplatin and sodium salicylate could remarkably augment P53 and caspase 3 levels.	Cisplatin	59-68	Wistar clone pR53P1 p53 pseudogene	Rattus norvegicus	116-119	
15289360-9	2004	In vitro study revealed that under hypoxic condition, both cisplatin and sodium salicylate could remarkably augment P53 and caspase 3 levels.	Cisplatin	59-68	caspase 3	Rattus norvegicus	124-133	
15289360-9	2004	In vitro study revealed that under hypoxic condition, both cisplatin and sodium salicylate could remarkably augment P53 and caspase 3 levels.	Sodium Salicylate	73-90	Wistar clone pR53P1 p53 pseudogene	Rattus norvegicus	116-119	
15289360-9	2004	In vitro study revealed that under hypoxic condition, both cisplatin and sodium salicylate could remarkably augment P53 and caspase 3 levels.	Sodium Salicylate	73-90	caspase 3	Rattus norvegicus	124-133	
15289360-10	2004	Cisplatin stimulated HIF-1alpha up-regulation, whereas sodium salicylate suppressed HIF-1alpha expression.	Cisplatin	0-9	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	21-31	
15289360-10	2004	Cisplatin stimulated HIF-1alpha up-regulation, whereas sodium salicylate suppressed HIF-1alpha expression.	Sodium Salicylate	55-72	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	84-94